The use of artificial intelligence applications in medicine and the standard required for healthcare provider-patient briefings-an exploratory study.

Introduction: Digital Health Technologies (DHTs) are currently being funneled through legacy regulatory processes that are not adapted to the unique particularities of this new technology class. In the absence of adequate regulation of DHTs, the briefing of a patient by their healthcare provider (HCP) as a component of informed consent can present the last line of defense before potentially harmful technologies are employed on a patient.

Methods: This exploratory study utilizes a case vignette of a machine learning-based technology for the diagnosis of ischemic heart disease that is presented to a group of medical students, physicians, and bioethicists.

The Use and Ethics of Digital Twins in Medicine.

Digital Health Technologies (DHTs) are currently the subject of much debate both in terms of their technological frontiers as well as their ethical, legal and societal implications (ELSI). Regulation of such technologies as medical devices currently lacks behind their level of adoption. Digital Twins are the next evolution step of such DHTs and provide an opportunity to anticipate and act on ELSI before adoption again leaps before the necessary review.